Effect of ondansetron hydrochloride on nausea and vomiting after transcatheter arterial embolization in patients with hepatocellular carcinoma
β Scribed by Hideyuki Nomura; Akemi Kawasaki; Yuko Mizuno; Ryousuke Hirakata
- Book ID
- 117091092
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 264 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0011-393X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Systemic, highβdose interferonβΞ± treatment given three times per week subcutaneously induces tumor regression in approximately 30% of patients with inoperable hepatocellular carcinoma (HCC). The objective of the current study was to determine the efficacy and safety of tr
Background. Modulation of serum levels of circulating cytokines and inflammatory responses with a serine protease inhibitor was studied in 34 patients with hepatocellular carcinoma (HCC) after transcatheter arterial embolization (TAE). Methods. The 34 patients were randomly divided into two groups: